Arumugham Raghunathan

Title: Arumugham Raghunathan: Innovator in Nucleic Acid Amplification

Introduction

Arumugham Raghunathan is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of nucleic acid amplification, which is crucial for various applications in biotechnology and medical diagnostics. His innovative approach has led to advancements that enhance the quality of amplification products.

Latest Patents

Raghunathan holds a patent for a "Method for nucleic acid amplification that results in low amplification bias." This patent discloses compositions and methods for amplifying nucleic acid sequences of interest. It has been discovered that amplification reactions can produce high-quality amplification products, such as low amplification bias, when performed on an amount of nucleic acid at or over a threshold amount and/or on nucleic acids at or below a threshold concentration. The threshold amount and concentration can vary depending on the nature and source of the nucleic acids to be amplified and the type of amplification reaction employed. The patent also includes a method for determining the threshold amount and/or threshold concentration of nucleic acids that can be used in amplification reactions.

Career Highlights

Arumugham Raghunathan is currently associated with Qiagen GmbH, a leading company in the field of molecular biology. His work at Qiagen has allowed him to further develop his innovative methods and contribute to the advancement of nucleic acid technologies.

Collaborations

Raghunathan has collaborated with notable colleagues, including Carole Bornarth and Michele Wisniewski. These collaborations have likely enriched his research and contributed to the successful development of his patented methods.

Conclusion

Arumugham Raghunathan's contributions to nucleic acid amplification represent a significant advancement in biotechnology. His innovative methods and collaborations continue to influence the field, paving the way for future developments.